MX2017006802A - Animales no humanos que expresan el complejo cd3 humanizado. - Google Patents

Animales no humanos que expresan el complejo cd3 humanizado.

Info

Publication number
MX2017006802A
MX2017006802A MX2017006802A MX2017006802A MX2017006802A MX 2017006802 A MX2017006802 A MX 2017006802A MX 2017006802 A MX2017006802 A MX 2017006802A MX 2017006802 A MX2017006802 A MX 2017006802A MX 2017006802 A MX2017006802 A MX 2017006802A
Authority
MX
Mexico
Prior art keywords
human animals
complex
animals expressing
expressing humanized
humanized
Prior art date
Application number
MX2017006802A
Other languages
English (en)
Inventor
Smith Eric
Venus Lai Ka-Man
J Murphy Andrew
Thurston Gavin
L Olson Kara
Guo Dayong
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54849703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017006802(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2017006802A publication Critical patent/MX2017006802A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se proporcionan animales no humanos que expresan proteínas CD3 humanizadas. Además, se proporcionan animales no humanos, por ejemplo, roedores, modificados genéticamente de manera que comprendan en su genoma proteínas CD3 humanizadas. Además, se proporcionan métodos y composiciones para preparar dichos animales no humanos, así como métodos de uso de dichos animales no humanos.
MX2017006802A 2014-11-24 2015-11-23 Animales no humanos que expresan el complejo cd3 humanizado. MX2017006802A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462083653P 2014-11-24 2014-11-24
US201562106999P 2015-01-23 2015-01-23
PCT/US2015/062229 WO2016085889A1 (en) 2014-11-24 2015-11-23 Non-human animals expressing humanized cd3 complex

Publications (1)

Publication Number Publication Date
MX2017006802A true MX2017006802A (es) 2018-01-30

Family

ID=54849703

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006802A MX2017006802A (es) 2014-11-24 2015-11-23 Animales no humanos que expresan el complejo cd3 humanizado.

Country Status (24)

Country Link
US (3) US20170164588A1 (es)
EP (3) EP3223605B9 (es)
JP (4) JP7018314B2 (es)
KR (2) KR20240055876A (es)
CN (2) CN113016720B (es)
AU (2) AU2015353705C9 (es)
BR (1) BR112017010793A2 (es)
CA (1) CA2967823A1 (es)
CY (1) CY1123714T1 (es)
DK (2) DK3223605T3 (es)
ES (2) ES2844000T3 (es)
HR (2) HRP20220904T1 (es)
HU (2) HUE052603T2 (es)
IL (2) IL286414B2 (es)
LT (2) LT3689140T (es)
MA (1) MA50679A (es)
MX (1) MX2017006802A (es)
PL (2) PL3689140T3 (es)
PT (2) PT3223605T (es)
RS (2) RS63410B1 (es)
RU (2) RU2020122439A (es)
SG (1) SG11201703800PA (es)
SI (2) SI3223605T1 (es)
WO (1) WO2016085889A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63410B1 (sr) * 2014-11-24 2022-08-31 Regeneron Pharma Ne-humane životinje koje eksprimiraju humanizovani cd3 kompleks
NZ731471A (en) 2014-12-05 2021-12-24 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 47 gene
US11612149B2 (en) 2015-07-10 2023-03-28 Chugai Seiyaku Kabushiki Kaisha Non-human animal having human CD3 gene substituted for endogenous CD3 gene
WO2017087780A1 (en) 2015-11-20 2017-05-26 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized lymphocyte-activation gene 3
ES2886958T3 (es) 2016-02-29 2021-12-21 Regeneron Pharma Roedores que tienen un gen TMPRSS humanizado
US11793180B2 (en) * 2016-08-22 2023-10-24 Chugai Seiyaku Kabushiki Kaisha Gene-modified mouse expressing human GPC3 polypeptide
AU2018295358A1 (en) * 2017-06-27 2020-01-16 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ASGR1 locus
RU2020112751A (ru) * 2017-09-29 2021-10-29 Регенерон Фармасьютикалз, Инк. Отличные от человека животные, у которых экспрессируется гуманизированный комплекс c1q
CA3076377A1 (en) 2017-11-30 2019-06-06 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized trkb locus
WO2019114768A1 (en) 2017-12-12 2019-06-20 Biocytogen Jiangsu Co., Ltd. GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD3e
EP3772926A1 (en) 2018-03-26 2021-02-17 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
US10463029B1 (en) * 2018-06-07 2019-11-05 Regeneron Pharmaceuticals, Inc. Rodent model of steel syndrome
SG11202011284RA (en) 2018-07-16 2020-12-30 Regeneron Pharma Non-human animal models of ditra disease and uses thereof
CN109355309B (zh) * 2018-10-18 2021-02-05 江苏集萃药康生物科技股份有限公司 一种cd3e基因修饰人源化动物模型的构建方法
WO2021018198A1 (en) * 2019-07-29 2021-02-04 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric il33
US20230148574A1 (en) * 2020-04-01 2023-05-18 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric cd38
JP2023523584A (ja) * 2020-04-24 2023-06-06 メモリアル スローン ケタリング キャンサー センター 抗ｃｄ３抗体及びその使用
EP4240833A1 (en) * 2020-11-06 2023-09-13 BioVentures, LLC T cells and bifunctional protein against human papillomavirus
CN112458117B (zh) * 2021-02-02 2021-05-04 百奥赛图(北京)医药科技股份有限公司 Cd155基因人源化的非人动物的构建方法及应用
EP4294180A1 (en) * 2021-02-19 2023-12-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric cd3 genes

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100246529B1 (ko) * 1990-12-14 2000-04-01 스티븐 에이. 서윈. 엠.디. 수용체 관련된 신호 변환 경로를 위한 키메라 사슬
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
FR2827302B1 (fr) * 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
JP4968498B2 (ja) 2002-01-23 2012-07-04 ユニバーシティ オブ ユタ リサーチ ファウンデーション ジンクフィンガーヌクレアーゼを用いる、標的化された染色体変異誘発
EP1344824A1 (en) * 2002-03-11 2003-09-17 Institut de la Santé et de la Recherche Médicale Mutated gene coding for a LAT protein and the biological applications thereof
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
UA94211C2 (ru) * 2004-06-03 2011-04-26 Новиммюн С.А. Выделенное полностью человеческое моноклональное cd3 антитело
CA2583750C (en) 2004-10-19 2015-11-24 Regeneron Pharmaceuticals, Inc. Methods for generating a rodent having a genetic modification
EP4059964A1 (en) * 2007-04-03 2022-09-21 Amgen Research (Munich) GmbH Cross-species-specific binding domain
PL2155788T3 (pl) * 2007-04-03 2013-02-28 Amgen Res Munich Gmbh Swoiste międzygatunkowe bispecyficzne czynniki wiążące
ES2695047T3 (es) 2007-04-03 2018-12-28 Amgen Research (Munich) Gmbh Dominio de unión específico entre especies
US8632768B2 (en) * 2008-05-30 2014-01-21 University Of Louisville Research Foundation, Inc. Human facilitating cells
SG194399A1 (en) * 2008-10-01 2013-11-29 Amgen Res Munich Gmbh Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody
WO2010085660A2 (en) * 2009-01-23 2010-07-29 Roger Williams Hospital Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
EP2460403B1 (en) 2009-07-31 2019-05-22 SMC Global Asset, Inc. Steatohepatitis-liver cancer model mouse
US8883496B2 (en) * 2009-12-21 2014-11-11 Regeneron Phamaceuticals, Inc. Humanized FcgR mice
WO2011079283A1 (en) * 2009-12-23 2011-06-30 Bioalliance C.V. Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same
KR102084927B1 (ko) 2011-10-28 2020-03-06 리제너론 파아마슈티컬스, 인크. 사람화된 ｉｌ-6 및 ｉｌ-6 수용체
HUE035652T2 (en) 2011-10-28 2018-05-28 Regeneron Pharma Genetically Modified Major Histocompatibility Complex Mice
ES2914374T3 (es) 2011-10-28 2022-06-10 Regeneron Pharma Ratones modificados genéticamente que expresan moléculas quiméricas del complejo de histocompatibilidad mayor (MHC) de clase II
CN107858332A (zh) * 2011-10-28 2018-03-30 瑞泽恩制药公司 T细胞受体基因修饰小鼠
WO2014028776A1 (en) * 2012-08-15 2014-02-20 Zyngenia, Inc. Monovalent and multivalent multispecific complexes and uses thereof
KR20150043342A (ko) * 2012-08-21 2015-04-22 글락소 그룹 리미티드 단일 가변 도메인 및 카모스타트 메실레이트 (cm)를 포함하는 조성물
EP2896291B1 (en) 2012-09-13 2019-03-20 Chugai Seiyaku Kabushiki Kaisha Gene knock-in non-human animal
JOP20200236A1 (ar) 2012-09-21 2017-06-16 Regeneron Pharma الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
BR112015007120A2 (pt) 2012-10-08 2017-12-12 Roche Glycart Ag anticorpo biespecífico, composição farmacêutica, uso, célula hospedeira e método de produção de um anticorpo
EP3939423B1 (en) 2012-11-05 2024-03-06 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals and methods of use thereof
TWI682941B (zh) 2013-02-01 2020-01-21 美商再生元醫藥公司 含嵌合恆定區之抗體
CN111484999A (zh) 2013-02-20 2020-08-04 瑞泽恩制药公司 人源化的t细胞共受体的小鼠
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
CA2900824A1 (en) 2013-02-22 2014-08-28 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
IL297607B2 (en) 2013-09-23 2024-01-01 Regeneron Pharma Non-human animals with a humanized gene for SIGNAL-REGULATORY PROTEIN
CN103509122B (zh) * 2013-09-23 2015-04-15 武汉友芝友生物制药有限公司 一种cd3抗原及其制备方法和用途
SG10201900003WA (en) 2013-11-19 2019-02-27 Regeneron Pharma Non-human animals having a humanized b-cell activating factor gene
TWI701042B (zh) 2014-03-19 2020-08-11 美商再生元醫藥公司 用於腫瘤治療之方法及抗體組成物
WO2015157415A1 (en) 2014-04-08 2015-10-15 Regeneron Pharmaceuticals, Inc. Non-human animals having humanized fc-gamma receptors
NO2785538T3 (es) 2014-05-07 2018-08-04
SG10202002187WA (en) 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
WO2015196051A1 (en) 2014-06-19 2015-12-23 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized programmed cell death 1 gene
RS63410B1 (sr) * 2014-11-24 2022-08-31 Regeneron Pharma Ne-humane životinje koje eksprimiraju humanizovani cd3 kompleks

Also Published As

Publication number Publication date
JP2021035397A (ja) 2021-03-04
KR20170120090A (ko) 2017-10-30
CA2967823A1 (en) 2016-06-02
EP3689140B1 (en) 2022-05-11
PT3223605T (pt) 2020-12-24
IL286414A (en) 2021-10-31
CN113016720A (zh) 2021-06-25
AU2015353705B2 (en) 2022-01-20
RU2017122038A3 (es) 2019-07-17
HUE059417T2 (hu) 2022-11-28
AU2022202578A1 (en) 2022-05-12
EP3223605A1 (en) 2017-10-04
AU2015353705C9 (en) 2022-09-01
CY1123714T1 (el) 2022-03-24
JP2023101757A (ja) 2023-07-21
IL252202A0 (en) 2017-07-31
KR20240055876A (ko) 2024-04-29
DK3689140T3 (da) 2022-08-01
PT3689140T (pt) 2022-07-27
PL3689140T3 (pl) 2022-09-05
HUE052603T2 (hu) 2021-05-28
MA50679A (fr) 2021-03-17
JP2022066476A (ja) 2022-04-28
EP3689140A1 (en) 2020-08-05
HRP20220904T1 (hr) 2022-10-14
RU2020122439A (ru) 2020-09-24
US11937587B2 (en) 2024-03-26
AU2015353705A1 (en) 2017-06-08
US20200275642A1 (en) 2020-09-03
KR102659123B1 (ko) 2024-04-22
RS61080B1 (sr) 2020-12-31
EP3223605B1 (en) 2020-10-14
BR112017010793A2 (pt) 2017-12-26
LT3223605T (lt) 2021-01-11
WO2016085889A1 (en) 2016-06-02
ES2844000T3 (es) 2021-07-21
RU2017122038A (ru) 2018-12-26
CN107105633B (zh) 2021-02-12
IL286414B2 (en) 2024-04-01
DK3223605T3 (da) 2020-11-16
IL286414B1 (en) 2023-12-01
AU2015353705C1 (en) 2022-08-11
RS63410B1 (sr) 2022-08-31
EP3223605B9 (en) 2021-08-18
EP4088572A1 (en) 2022-11-16
JP7269214B2 (ja) 2023-05-08
JP7018314B2 (ja) 2022-02-10
SI3223605T1 (sl) 2021-03-31
SG11201703800PA (en) 2017-06-29
JP2017536126A (ja) 2017-12-07
CN113016720B (zh) 2023-02-21
US10932455B2 (en) 2021-03-02
CN107105633A (zh) 2017-08-29
IL252202B (en) 2021-10-31
HRP20201938T1 (hr) 2021-02-05
SI3689140T1 (sl) 2022-10-28
LT3689140T (lt) 2022-08-25
PL3223605T3 (pl) 2021-04-19
US20170164588A1 (en) 2017-06-15
RU2726446C2 (ru) 2020-07-14
US20210100229A1 (en) 2021-04-08
ES2923775T3 (es) 2022-09-30

Similar Documents

Publication Publication Date Title
MX2017006802A (es) Animales no humanos que expresan el complejo cd3 humanizado.
MX2016016903A (es) Animales no humanos que tienen un gen de muerte celular programada 1 humanizado.
PH12016500342A1 (en) Non-human animals having a humanized signal-regulatory protein gene
MX2021010351A (es) Animales no humanos que expresan desoxinucleotidil transferasa terminal exogena.
WO2016106159A8 (en) Anti-pd-1 antibodies
MX2017007293A (es) Animales no humanos que tienen un gen del grupo de diferenciacion 47 humanizado.
MX355726B (es) Ratones transgenicos que expresan moleculas quimericas del complejo mayor de histocompatibilidad (cmh) clase ii.
MY178723A (en) Genetically modified major histocompatibility complex mice
MX2017007636A (es) Animales no humanos que tienen un gen del grupo de diferenciacion 274 humanizado.
MX2019005251A (es) Animales no humanos geneticamente modificados y metodos de uso de los mismos.
MX2019002482A (es) Animales geneticamente modificados y metodo para su obtencion.
MX361533B (es) Anticuerpos anti-cd22.
MX2019000641A (es) Composiciones de mucina1-receptor de antigeno quimerico y metodos para su uso.
MX2021014818A (es) Anticuerpos monoclonales anti-cd303.
MX2016013241A (es) Animales no humanos que tienen receptores fc gamma humanizados.
TW201613893A (en) Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
MY183188A (en) Non-human animals having a humanized b-cell activating factor gene
MX2016006513A (es) Animales no humanos que tienen un gen humanizado de un ligando inductor de la proliferacion.
EP4249507A3 (en) Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules
MY182065A (en) Lincrna-deficient non-human animals
PH12016502024A1 (en) Tonoplast proton/sugar antiporter proteins and the use thereof to increase the saccharose concentration in a saccharose storage organ of plants
MX2019002307A (es) Anticuerpos multiespecificos que facilitan el emparejamiento selectivo de cadenas ligeras.
NZ719493A (en) Compositions and methods for producing genetically modified animals
MX2015011279A (es) Plantas de maiz con resistencia mejorada a patogenos.